文献速递乳腺癌放疗放疗物理与技术

乳腺癌IMRT后窦房结放疗剂量与新发心电图异常的关联

Association Between Sinoatrial Node Radiation Dose and New-Onset Electrocardiogram Abnormalities After Breast Cancer Intensity Modulated Radiation Therapy.
PubMed 文献 · Pract Radiat Oncol · 2026-09-15

该回顾性队列纳入91例术后接受IMRT的乳腺癌患者,按已发表勾画指南回顾性勾画窦房结等心脏亚结构。中位随访9.0个月,3、6、12个月新发心电图异常累积发生率分别为17.6%、38.3%、76.7%。多因素分析显示平均心脏剂量和窦房结V5Gy是新发心电图异常的独立相关因素。

要点

  • 平均心脏剂量每增加1 Gy,新发心电图异常风险升高(HR=1.28)。
  • 探索性窦房结V5Gy≥3%与新发心电图异常风险升高相关(HR=1.71)。
  • 心脏亚结构剂量学可能提供超越平均心脏剂量的额外信息。

核心结论

  • 在该探索性回顾性队列中,窦房结放疗暴露与IMRT后新发心电图异常相关。
  • 心脏亚结构剂量学可能提供超越常规平均心脏剂量评估的额外信息。

研究设计与样本

  • 按已发表勾画指南回顾性勾画窦房结、房室结、心室和冠状动脉等心脏亚结构进行剂量分析。
  • 采用Kaplan-Meier法估计新发心电图异常累积发生率,多因素Cox比例风险回归分析独立剂量学因素。

主要发现

  • 中位随访9.0个月,3、6、12个月新发心电图异常累积发生率分别为17.6%、38.3%、76.7%。
  • 多因素分析确定平均心脏剂量和窦房结V5Gy是与新发心电图异常相关的强独立因素。
  • 平均心脏剂量每增加1 Gy与新发心电图异常风险升高相关(HR=1.28;95%CI 1.09-1.50;P=.002)。
  • 探索性窦房结V5Gy阈值≥3%与新发心电图异常风险升高相关(HR=1.71;P=.003)。

关键数值与推荐

  • 探索性窦房结V5Gy阈值≥3%与新发心电图异常风险升高相关(HR=1.71;P=.003)。
  • 平均心脏剂量每增加1 Gy与新发心电图异常风险升高相关(HR=1.28;95%CI 1.09-1.50;P=.002)。

临床怎么用

  • 乳腺癌IMRT计划评估时可考虑关注窦房结等心脏亚结构剂量,作为平均心脏剂量之外的补充信息。
  • 对窦房结V5Gy≥3%等探索性阈值需谨慎解读,尚需进一步研究验证。

局限性

  • 本研究为探索性回顾性队列,样本量91例,中位随访仅9.0个月。
  • 窦房结V5Gy≥3%阈值为探索性分析结果,需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the association between cardiac conduction system dosimetry, specifically the sinoatrial node (SAN), for new-onset electrocardiogram (ECG) abnormalities in patients with breast cancer undergoing intensity modulated radiation therapy (IMRT). METHODS AND MATERIALS: We retrospectively reviewed 91 patients with breast cancer treated with postoperative IMRT between October 2023 and May 2024. Cardiac substructures, including the SAN, atrioventricular node, ventricles, and coronary arteries, were retrospectively delineated according to previously published contouring guidelines for dosimetric analysis. The cumulative incidence of new-onset ECG abnormalities was estimated using the Kaplan-Meier method. Independent dosimetric factors associated with new-onset ECG abnormalities were identified using multivariate Cox proportional hazards regression analysis. RESULTS: At a median follow-up of 9.0 months, the estimated cumulative incidences of new-onset ECG abnormalities at 3, 6, and 12 months, based on Kaplan-Meier analysis, were 17.6%, 38.3%, and 76.7%, respectively. Multivariate analysis identified mean heart dose (MHD) and the SAN volume receiving ≥5 Gy as potent independent factors associated with new-onset ECG abnormalities. Each 1-Gy increase in MHD was associated with a higher risk of new-onset ECG abnormalities (hazard ratio = 1.28; 95% CI, 1.09-1.50; P = .002). An exploratory SAN volume receiving ≥5 Gy threshold of ≥3% was associated with an increased risk of new-onset ECG abnormalities (hazard ratio = 1.71; P = .003). CONCLUSIONS: In this exploratory retrospective cohort, SAN radiation exposure was associated with new-onset ECG abnormalities after IMRT. These findings suggest that cardiac substructure dosimetry may provide additional information beyond conventional MHD assessment.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Chi Z, Wang F, et al. Association Between Sinoatrial Node Radiation Dose and New-Onset Electrocardiogram Abnormalities After Breast Cancer Intensity Modulated Radiation Therapy. Pract Radiat Oncol. 2026. PMID: 42744089. doi:10.1016/j.prro.2026.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。